Sense Biodetection Limited

Sense is transforming healthcare by redefining diagnostics. Our Veros™ instrument-free molecular platform empowers doctors and patients by delivering diagnostic results that can be trusted, in a way never thought possible.

 

Backed by some of the most respected venture capital firms in the world, we are a rapidly growing Company that is launching an entirely new class of diagnostic product: a rapid, disposable, instrument-free molecular product platform delivering the “gold standard” performance of laboratory testing without the constraints of costly instruments or readers.

 

We believe our approach enables better access, better outcomes, and better value across every aspect of healthcare.  Sense is aggressively growing from its strong research and development foundation and emerging as the global leader in this exciting new segment of healthcare.